Ims Euro Limited
Registered name: IMS EURO LIMITED
Part of Elysian Capital III LP groupIms Euro Limited made £32.9m revenue and £5.5m profit in the year to 31 Dec 2025.
Ims Euro Limited’s revenue was £32.9m in the year to 31 Dec 2025, with £5.5m profit and 83 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Stockport; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Stockport, North West
- Age
- 25 yrs · since 2001
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “IMS Euro Group Limited”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £19.5m | £27.2m | £33m | £32.9m |
| Cost of sales | £13.4m | £18.9m | £22.6m | £23.5m |
| Gross profit | £6m | £8.3m | £10.4m | £9.5m |
| Operating profit | £2.2m | £3.3m | £4.5m | £5.5m |
| Profit before tax | £2.2m | £3.3m | £4.5m | £5.5m |
| Profit after tax | £1.8m | £2.5m | £3.4m | £5.5m |
| Profit (best available) | £1.8m | £2.5m | £3.4m | £5.5m |
| Staff costs | £2.8m | £3.5m | £3.9m | £3.7m |
| Employees (average) | 74 | 81 | 95 | 83 |
| Ratios | ||||
| Profit margin | 9.1% | 9.3% | 10.3% | 16.7% |
| Gross margin | 31% | 30.5% | 31.5% | 28.8% |
| Revenue per employee | £263k | £336k | £347k | £397k |
| Profit per employee | £23.9k | £31.1k | £35.8k | £66.1k |
| Growth (year on year) | ||||
| Revenue growth | — | ▲39.8% | ▲21.2% | ▼0.2% |
| Profit growth | — | ▲42.5% | ▲35.1% | ▲61.1% |
| Headcount growth | — | ▲9.5% | ▲17.3% | ▼12.6% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £281k | £1.3m | £5m | £6.7m |
| Net assets | £6.5m | £8.8m | £11.9m | £17.4m |
| Fixed assets | £66.6k | £81.3k | £108k | £286k |
| Current assets | £9m | £13.8m | £17.3m | £21.8m |
| Debtors | £2.9m | £4.2m | £3.4m | £7.1m |
| Source | FullAccounts · bulk data Aug 2024 | FullAccounts · bulk data Aug 2024 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 16.7%
- Profit ÷ revenue.
- Gross margin
- 28.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £397k
- Revenue ÷ average employees.
- Profit per employee
- £66.1k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.9%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 21.4%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲46%
- Now £17.4m
- Cash at bank
- ▲35%
- Now £6.7m
- Headcount
- ▼13%
- Now 83
- Deferred income
- —
- Now —
- Fixed assets
- ▲164%
- Now £286k
Group structure
Ownership chain
- Elysian Capital III LPultimate parent75–100%
- Ims Euro Topco Limited75–100%
- Ims Euro Midco 1 Limited75–100%
- Ims Euro Midco 2 Limited75–100%
- Ims Euro Bidco Limited75–100%
- Ims Euro Group Ltd75–100%
- Ims Euro Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Paul Murray PLCSouthampton · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £1.7m
- Staff
- 92
- Medreich PLCFeltham · Wholesale of pharmaceutical goods
- Revenue
- £32.7m
- Profit
- £440k
- Staff
- 32
- Bowmed Ibisqus LimitedManchester · Wholesale of pharmaceutical goods
- Revenue
- £32m
- Profit
- £3.4m
- Staff
- 11
- Beta Pharmaceuticals LimitedWitham · Wholesale of pharmaceutical goods
- Revenue
- £34.3m
- Profit
- £120k
- Staff
- 61
- Attends LimitedWakefield · Wholesale of pharmaceutical goods
- Revenue
- £35.9m
- Profit
- £635k
- Staff
- 23
- New England Biolabs (U.K.) LimitedHitchin · Wholesale of pharmaceutical goods
- Revenue
- £36m
- Profit
- £1.8m
- Staff
- 44
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £5.5m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.